PTPN5 and Alzheimer disease: Pyk2 levels or activity may be deficient in some neurodegenerative conditions such as in HD or AD, where this deficit can contribute to alterations in synaptic functions and behavior that are improved by expression of Pyk2 or inhibition of the major Pyk2 phosphatase STEP.